Put companies on watchlist
SYNBIOTIC SE
ISIN: DE000A3E5A59
WKN: A3E5A5
About
Company Snapshot
New: Enable Investor Alerts
Be informed about new publications
New: AI Factsheet

Corporate News meets AI! 
Content analysis and summary

EN GIF 300X250

SYNBIOTIC SE · ISIN: DE000A3E5A59 · EQS - Company News (29 News)
Country: Germany · Primary market: Germany · EQS NID: 1889627
25 April 2024 12:33PM

Federal Ministry for Economic Affairs and Climate Protection funds bio-economy project


EQS-News: SYNBIOTIC SE / Key word(s): Financing
1.6 million euros for Hanf Farm: Federal Ministry for Economic Affairs and Climate Protection funds bio-economy project (news with additional features)

25.04.2024 / 12:33 CET/CEST
The issuer is solely responsible for the content of this announcement.


The Federal Ministry for Economic Affairs and Climate Protection (BMWK) is funding a Hanf Farm project in the field of industrial bio-economy with 1.6 million euros. The official funding decision has now been handed over to Managing Director Rafael Dulon and Project Manager Michael Bieder by State Secretary Stefan Wenzel at the Hanover Trade Fair. Wenzel recognised the importance of research and development in the field of bio-economy when handing over the decision. Hanf Farm GmbH is a company of the German industrial hemp and cannabis group SYNBIOTIC SE.

The funding serves to advance the planning and implementation of automated and AI-supported production for processing biogenic raw materials, including hemp, miscanthus and crops from the agricultural use of peatland sites. The project and the funding from the BMWK mark a significant breakthrough in the sustainable production and development of the industrial bio-economy.

Rafael Dulon, Managing Director of Hanf Farm: "We are very grateful for the financial support from the BMWK. The funding enables us to realise our vision of sustainable and efficient production of organic raw materials and to make an important contribution to the development of the industrial bio-economy."

Michael Bieder, Project Manager Hanf Farm: "The project is a milestone in the field of industrial bio-economy. For the first time, the BMWK is funding the planning and implementation of a fully automated and AI-supported factory for industrial hemp and lignocellulosic fibre raw materials. This innovative approach not only promises to increase efficiency and sustainability in production, but also paves the way for future developments in this area."

Hanf Farm GmbH is a leading company in the field of sustainable organic raw material production and sees the funding from the BMWK as confirmation of its efforts to create a future-orientated and environmentally conscious economy.

The photo shows from left to right Claudia van Veen (moderator), Michael Bieder (Project Manager Hanf Farm), Rafael Dulon (Managing Director Hanf Farm) and State Secretary Stefan Wenzel (BMWK).

About Hanf Farm
Hanf Farm GmbH specialises in the cultivation, processing and global marketing of high-quality hemp products. The aim is to establish hemp as a cultivated plant in Germany and Europe and to integrate it into agricultural cycles. Hanf Farm GmbH attaches great importance to producing innovative and sustainably valuable products and to taking equal account of ecological, social and economic aspects. Hanf Farm GmbH is a company of the industrial hemp and cannabis group SYNBIOTIC SE.

About SYNBIOTIC
SYNBIOTIC is a listed group of companies in the hemp and cannabis sector and pursues a buy and build investment strategy focussed on the EU. The group covers the entire value chain from cultivation to production and retail - from the field to the shelf. The core businesses of the vertically integrated company are research and development, production and commercialisation of hemp, CBD and cannabis products. SYNBIOTIC has a clear strategy to further expand along the value chains of its business areas - hemp and CBD, medical cannabis and consumer cannabis.

Publisher
Hanf Farm GmbH
Rafael Dulon | Managing Director
Dorfstraße 58
17209 Melz
Germany

Media contact Hanf Farm
Michael Bieder
Landline +49 39923 714758
E-mail michael.bieder@hanffarm.de
Internet www.hanffarm.de

Media contact SYNBIOTIC
Rüdiger Tillmann
SYNBIOTIC
Public Relations Manager
E-mail ruediger.tillmann@synbiotic.com
Mobile +49 171 3677028
c/o JOLE.group

Additional features:

File: SBX Hanf Farm BMWK


25.04.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: SYNBIOTIC SE
Münsterstr. 336
40470 Dusseldorf
Germany
E-mail: office@synbiotic.com
Internet: https://www.synbiotic.com/
ISIN: DE000A3E5A59
WKN: A3E5A5
Listed: Regulated Unofficial Market in Berlin, Dusseldorf, Frankfurt, Munich, Tradegate Exchange
EQS News ID: 1889627

 
End of News EQS News Service

1889627  25.04.2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1889627&application_name=news&site_id=boersengefluester~~~ace3d64b-2049-452a-8d18-fbc8044c4b5f
Visual performance / price development - SYNBIOTIC SE
Smart analysis and research tools can be found here.

This publication was provided by our content partner EQS3.

EQS Newswire
via EQS - Newsfeed
EQS Group AG ©2024
(DGAP)
Contact:
Karlstraße 47 D-80333 München
+49 (0) 89 444 430-000

 

SMART * AD
EN GIF 970X250

P R O D U C T   S U G G E S T I O N S

The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.


The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.

If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.

For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.


1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.